Publication | Closed Access

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

VaccinationVaccine SafetyInterim AnalysisPreventive MedicinePhase Iii Double-blindHuman Papillomavirus VaccinesVirologyVaccine EfficacyYoung WomenPolyvalent VaccineMedicineVaccine Research